Alere Company Profile (NYSE:ALR)

About Alere

Alere logoAlere Inc. is a provider of health information through diagnostic tests. The Company operates through professional diagnostics, patient self-testing, consumer diagnostics and, corporate and other segments. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The patient-self testing segment provides services designed to provide physicians with actionable data that allow them to make decisions in real time, deliver care, and put the individuals they treat on a pathway to better health. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its 50/50 joint venture with The Procter & Gamble Company (P&G).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Supplies
  • Exchange: NYSE
  • Symbol: ALR
  • CUSIP: 01449J10
Key Metrics:
  • Previous Close: $39.35
  • 50 Day Moving Average: $39.97
  • 200 Day Moving Average: $44.51
  • 52-Week Range: $31.47 - $54.79
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 15.06
  • P/E Growth: 1.66
  • Market Cap: $3.40B
  • Outstanding Shares: 86,740,000
  • Beta: 1.4
Additional Links:
Companies Related to Alere:

Analyst Ratings

Consensus Ratings for Alere (NYSE:ALR) (?)
Ratings Breakdown: 4 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $52.13 (32.60% upside)

Analysts' Ratings History for Alere (NYSE:ALR)
DateFirmActionRatingPrice TargetDetails
8/18/2016BTIG ResearchReiterated RatingBuy$48.00View Rating Details
8/4/2016Jefferies GroupReiterated RatingHoldView Rating Details
7/28/2016Canaccord GenuitySet Price TargetBuy$56.00View Rating Details
7/12/2016Leerink SwannReiterated RatingBuy$56.00View Rating Details
4/29/2016Craig HallumUpgradeHold -> BuyView Rating Details
2/2/2016Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
2/1/2016Goldman Sachs Group Inc.DowngradeBuy -> Neutral$47.00 -> $56.00View Rating Details
11/5/2015WedbushLower Price TargetNeutral$43.00 -> $39.00View Rating Details
2/12/2015Citigroup Inc.DowngradeMarket WeightView Rating Details
10/3/2014ING GroupInitiated CoverageBuy$48.00View Rating Details
(Data available from 8/30/2014 forward)


Earnings History for Alere (NYSE:ALR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/17/2016Q116$0.56($0.18)$578.00 millionViewN/AView Earnings Details
8/8/2016Q415$0.58($0.28)$662.04 million$623.00 millionViewN/AView Earnings Details
11/4/2015Q315$0.61$0.54$646.29 million$602.00 millionViewN/AView Earnings Details
8/4/2015Q215$0.54$0.54$625.67 million$629.00 millionViewN/AView Earnings Details
5/5/2015Q115$0.49$0.57$612.93 million$610.40 millionViewN/AView Earnings Details
2/10/2015Q414$0.63$0.60$698.56 million$666.90 millionViewN/AView Earnings Details
10/28/2014Q314$0.52$0.48$743.30 million$736.20 millionViewN/AView Earnings Details
8/4/2014Q214$0.58$0.42$747.55 million$738.30 millionViewN/AView Earnings Details
4/29/2014Q114$0.55$0.55$738.70 million$716.60 millionViewN/AView Earnings Details
2/6/2014Q413$0.62$0.68$770.70 million$772.30 millionViewN/AView Earnings Details
10/29/2013Q313$0.53$0.59$737.66 million$753.90 millionViewN/AView Earnings Details
7/31/2013Q2 2013$0.48$0.64$720.24 million$764.00 millionViewN/AView Earnings Details
5/9/2013Q1 2013$0.51$0.53$727.66 million$739.20 millionViewN/AView Earnings Details
2/15/2013Q4 2012$0.57$0.55$714.75 million$755.80 millionViewN/AView Earnings Details
11/8/2012Q312$0.53$0.43$690.76 million$691.40 millionViewN/AView Earnings Details
8/8/2012$0.53($0.23)ViewN/AView Earnings Details
4/30/2012$0.67$0.77ViewN/AView Earnings Details
2/8/2012$0.71$0.74ViewN/AView Earnings Details
10/26/2011$0.57$0.67ViewN/AView Earnings Details
7/27/2011$0.58$0.46ViewN/AView Earnings Details
4/27/2011$0.61$0.61ViewN/AView Earnings Details
2/17/2011$0.66$0.71ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Alere (NYSE:ALR)
Current Year EPS Consensus Estimate: $2.38 EPS
Next Year EPS Consensus Estimate: $2.61 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.41$0.41$0.41
Q2 20161$0.54$0.54$0.54
Q3 20161$0.49$0.49$0.49
Q4 20161$0.65$0.65$0.65
(Data provided by Zacks Investment Research)


Dividend History for Alere (NYSE:ALR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Alere (NYSE:ALR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2016Melissa GuerdanSVPSell2,500$54.00$135,000.00View SEC Filing  
11/13/2015Robert Bernard HargadonSVPBuy1,000$38.99$38,990.00View SEC Filing  
11/12/2015James F HinrichsCFOBuy10,000$39.97$399,700.00View SEC Filing  
9/3/2015Mark GladwellVPSell2,651$52.27$138,567.77View SEC Filing  
9/3/2015Melissa GuerdanSVPSell5,135$52.00$267,020.00View SEC Filing  
9/1/2015Melissa GuerdanSVPSell5,000$50.48$252,400.00View SEC Filing  
8/31/2015Mark GladwellVPSell27,513$52.23$1,437,003.99View SEC Filing  
8/14/2015Sanjay MalkaniInsiderSell31,460$54.60$1,717,716.00View SEC Filing  
6/8/2015Sanjay MalkaniInsiderSell24,331$50.87$1,237,717.97View SEC Filing  
6/4/2015Sanjay MalkaniInsiderSell15,669$52.18$817,608.42View SEC Filing  
6/1/2015John BridgenSVPSell7,500$51.19$383,925.00View SEC Filing  
4/6/2015Melissa GuerdanSVPSell2,500$50.00$125,000.00View SEC Filing  
3/23/2015Melissa GuerdanSVPSell13,476$48.35$651,564.60View SEC Filing  
3/17/2015John BridgenSVPSell25,000$48.53$1,213,250.00View SEC Filing  
3/16/2015Carla FlakneCAOSell8,500$48.99$416,415.00View SEC Filing  
1/16/2015Carla FlakneCAOSell10,000$42.45$424,500.00View SEC Filing  
12/24/2014Don DudekDirectorBuy40,000$0.01$500.00
12/11/2014John BridgenSVPSell50,000$37.07$1,853,500.00View SEC Filing  
8/15/2014Dave TeitelCFOSell10,000$35.07$350,700.00View SEC Filing  
8/15/2013Dave TeitelCFOSell10,000$31.73$317,300.00View SEC Filing  
8/5/2013Michael Lester CottonInsiderSell12,500$33.82$422,750.00View SEC Filing  
5/31/2013Michael Lester CottonInsiderSell8,750$25.86$226,275.00View SEC Filing  
3/5/2013John QuelchDirectorSell20,220$23.49$474,967.80View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Alere (NYSE:ALR)
News IconWall Street Ratings and Update on Alere Inc. (NYSE:ALR) - Post News (NYSE:ALR) - August 29 at 4:03 PM logoBenzinga's M&A Chatter for Friday August 26, 2016 - Benzinga (NYSE:ALR) - August 29 at 8:11 AM
News IconAlere Pulls Abbott to Court over Merger Deal (NYSE:ALR) - August 27 at 8:13 AM
News IconAlere Drags Abbott to Court to Force Completion of $5.8 Billion Deal (NYSE:ALR) - August 27 at 8:13 AM logoAlere sues Abbott to complete $5.8B merger (NYSE:ALR) - August 27 at 8:13 AM logoAbbott's Acquisitions in Question as Issues Arise About Alere, St. Jude (NYSE:ALR) - August 27 at 8:13 AM logoAlere sues Abbott over $5.8 billion takeover (NYSE:ALR) - August 26 at 3:26 PM logoUPDATE 2-Alere sues Abbott over $5.8 bln takeover (NYSE:ALR) - August 26 at 2:23 PM logoUPDATE 1-Alere drags Abbott to court over $5.8 bln deal (NYSE:ALR) - August 26 at 1:57 PM logoAlere (ALR) Files Complaint Against Abbott (ABT) Regarding Merger (NYSE:ALR) - August 26 at 11:34 AM logoAlere Issues Statement (NYSE:ALR) - August 26 at 11:34 AM logoAlere Files Suit Against Abbott on $5.8 Billion Takeover Deal (NYSE:ALR) - August 26 at 11:34 AM logoAlere drags Abbott to court over $5.8 bln deal (NYSE:ALR) - August 26 at 11:34 AM logoAlere drags Abbott to court over $5.8 billion deal (NYSE:ALR) - August 26 at 11:34 AM logoETF’s with exposure to Alere, Inc. : August 25, 2016 (NYSE:ALR) - August 25 at 3:27 PM logoAlere Inc. (NYSE:ALR) Reports Change of $-5.925 MILLION IN Assets & Liabilities - (NYSE:ALR) - August 25 at 8:14 AM logoAlere, Inc. breached its 50 day moving average in a Bullish Manner : ALR-US : August 24, 2016 (NYSE:ALR) - August 24 at 11:42 AM logoAlere (ALR) Receives FDA Approval for RSV Molecular Test - Yahoo Finance (NYSE:ALR) - August 23 at 8:34 AM logoCurrent report in compliance with Regulation no. 1/2006 of NSC and with the stipulations of article no. 225 of the Capital Markets Law no. 297/2004 (NYSE:ALR) - August 23 at 8:34 AM logoPFE, SUPN Get FDA Nod, SNY Will Have To Wait Till Nov., Xenetic On The Move (NYSE:ALR) - August 22 at 8:14 AM logoAlere (ALR) Receives FDA Approval for RSV Molecular Test (NYSE:ALR) - August 22 at 8:14 AM logoFDA OKs Alere's rapid molecular RSV test - Seeking Alpha (NYSE:ALR) - August 20 at 8:25 AM
News IconAlere Inc. (NYSE: ALR) Buy Rating Reiterated at BTIG Research - BNB Daily (blog) (NYSE:ALR) - August 20 at 8:25 AM logoAlere Gets 510 (k) Marketing Authorisation For Alere I RSV Rapid Molecular Test (NYSE:ALR) - August 19 at 11:49 AM logoAlere's (ALR) i RSV Test Cleared by FDA (NYSE:ALR) - August 19 at 11:49 AM logoAlere Receives FDA Clearance for Alere™ i RSV Rapid Molecular Test (NYSE:ALR) - August 19 at 11:49 AM logoAcquisition of Shares under the Tender Offer for the Sale of Shares in Bank BPH S.A. (NYSE:ALR) - August 19 at 11:49 AM logoBRIEF-Alere gets FDA clearance for its RSV rapid molecular test (NYSE:ALR) - August 19 at 7:36 AM logoALERE INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NYSE:ALR) - August 18 at 8:54 PM logoBRIEF-Alere entered into a second amendment to secured credit agreement (NYSE:ALR) - August 18 at 5:56 PM
News IconHit List News Buzzer- Alere Inc. (NYSE:ALR), The Children's Place (NASDAQ:PLCE), Apple Inc. (NASDAQ:AAPL) - Seneca Globe (NYSE:ALR) - August 18 at 11:50 AM logoAlere Inc. (NYSE:ALR) Reports Accounts Payable Of $195.752 - (NYSE:ALR) - August 18 at 11:50 AM
News IconAlere Inc. (NYSE: ALR) announces quarterly earnings - BNB Daily (blog) (NYSE:ALR) - August 18 at 11:50 AM logoEARNINGS SUMMARY: Details of Alere Inc. Q1 Earnings Report (NYSE:ALR) - August 17 at 11:41 AM logoAlere reports 1Q loss (NYSE:ALR) - August 17 at 11:41 AM logoAlere revenues off 6% in Q1 (NYSE:ALR) - August 17 at 6:58 AM logoALERE INC. Financials (NYSE:ALR) - August 13 at 3:26 PM logoAlro has been selected as provider of aluminium products by Airbus (NYSE:ALR) - August 12 at 11:59 AM logoAlro reported an adjusted net profit* of RON 64 million, in a high volatility market (NYSE:ALR) - August 12 at 11:59 AM
News IconAlere Inc (NYSE:ALR) is Under The Radar Brokerage Ratings - The Voice Registrar (NYSE:ALR) - August 11 at 3:28 PM logoALERE INC. Files SEC form 8-K, Other Events (NYSE:ALR) - August 10 at 9:53 PM logoBRIEF-Alere Inc files for non-timely 10-Q - SEC Filing (NYSE:ALR) - August 10 at 6:01 PM logoAlere Inc. (ALR) is Trading Higher on Unusual Volume for August 08 - (NYSE:ALR) - August 10 at 10:28 AM logoCommit To Buy Alere At $32, Earn 12.8% Annualized Using Options (NYSE:ALR) - August 9 at 10:03 PM logoAlere Inc. (ALR) is Trading Higher on Unusual Volume for August 08 (NYSE:ALR) - August 9 at 10:03 PM
News IconHeavy Volume Healthcare Stocks: Alere Inc. (NYSE:ALR), MannKind Corp. (NASDAQ:MNKD) - TWN (NYSE:ALR) - August 9 at 12:11 PM
News IconAlere Inc (NYSE:ALR) & Archer Daniels Midland Company (NYSE:ADM) Trend Analysis Report - Money News (press release) (NYSE:ALR) - August 9 at 12:11 PM logoAlere Achieves IVD CE Mark for its Alere™ Reader Lateral Flow Assay Analyzer (NYSE:ALR) - August 9 at 12:11 PM logo7:04 am Alere achieves In-Vitro Diagnostic CE marking in Europe for its new Alere Reader (NYSE:ALR) - August 9 at 12:11 PM logoAlere reports 4Q loss (NYSE:ALR) - August 8 at 3:29 PM


Alere (NYSE:ALR) Chart for Tuesday, August, 30, 2016

Last Updated on 8/30/2016 by Staff